Department of Medicine, Sarah C. Upham Division of Gastroenterology, New York Medical College, Valhalla.
A second generation of tissue sensitizers has been formulated for the photodynamic ablation of cancer. The photophysical and biologic properties of these agents will determine their activity and clinical use. Investigations of sensitizer properties are discussed, providing a foundation for sensitizer selection, followed by a summary of clinical reports. Tissue sensitizers may be particularly effective for the noninvasive ablation of early cancers.